Double-Biguanide Therapy for Resistant Acanthamoeba Keratitis

Aims: To report the clinical and diagnostic findings of a patient with Acanthamoeba keratitis resistant to both polyhexamethylene biguanide (PHMB)-hexamidine and chlorhexidine-hexamidine treatment. Methods: Slit-lamp biomicroscopy, corneal cell scraping and histopathology were performed on a 39-year...

Full description

Bibliographic Details
Main Authors: Giulio Ferrari, Stanislav Matuska, Paolo Rama
Format: Article
Language:English
Published: Karger Publishers 2011-11-01
Series:Case Reports in Ophthalmology
Subjects:
Online Access:http://www.karger.com/Article/FullText/334270
id doaj-93c820fdccff4b72be5c86f839168a2e
record_format Article
spelling doaj-93c820fdccff4b72be5c86f839168a2e2020-11-25T02:31:24ZengKarger PublishersCase Reports in Ophthalmology1663-26992011-11-012333834210.1159/000334270334270Double-Biguanide Therapy for Resistant Acanthamoeba KeratitisGiulio FerrariStanislav MatuskaPaolo RamaAims: To report the clinical and diagnostic findings of a patient with Acanthamoeba keratitis resistant to both polyhexamethylene biguanide (PHMB)-hexamidine and chlorhexidine-hexamidine treatment. Methods: Slit-lamp biomicroscopy, corneal cell scraping and histopathology were performed on a 39-year-old woman presenting with corneal ulcer in her left eye. Results: The patient was successfully treated with PHMB-chlorhexidine association therapy. Subsequent perforating keratoplasty remained clear at the last follow-up visit after 7 months and increased visual acuity to 20/20 with correction. Conclusions: This case emphasizes the proteiform aspects of Acanthamoeba drug resistance, and suggests that PHMB-chlorhexidine association might represent an additional option for cases resistant to standard therapy.http://www.karger.com/Article/FullText/334270Acanthamoeba keratitisBiguanideDiamidine
collection DOAJ
language English
format Article
sources DOAJ
author Giulio Ferrari
Stanislav Matuska
Paolo Rama
spellingShingle Giulio Ferrari
Stanislav Matuska
Paolo Rama
Double-Biguanide Therapy for Resistant Acanthamoeba Keratitis
Case Reports in Ophthalmology
Acanthamoeba keratitis
Biguanide
Diamidine
author_facet Giulio Ferrari
Stanislav Matuska
Paolo Rama
author_sort Giulio Ferrari
title Double-Biguanide Therapy for Resistant Acanthamoeba Keratitis
title_short Double-Biguanide Therapy for Resistant Acanthamoeba Keratitis
title_full Double-Biguanide Therapy for Resistant Acanthamoeba Keratitis
title_fullStr Double-Biguanide Therapy for Resistant Acanthamoeba Keratitis
title_full_unstemmed Double-Biguanide Therapy for Resistant Acanthamoeba Keratitis
title_sort double-biguanide therapy for resistant acanthamoeba keratitis
publisher Karger Publishers
series Case Reports in Ophthalmology
issn 1663-2699
publishDate 2011-11-01
description Aims: To report the clinical and diagnostic findings of a patient with Acanthamoeba keratitis resistant to both polyhexamethylene biguanide (PHMB)-hexamidine and chlorhexidine-hexamidine treatment. Methods: Slit-lamp biomicroscopy, corneal cell scraping and histopathology were performed on a 39-year-old woman presenting with corneal ulcer in her left eye. Results: The patient was successfully treated with PHMB-chlorhexidine association therapy. Subsequent perforating keratoplasty remained clear at the last follow-up visit after 7 months and increased visual acuity to 20/20 with correction. Conclusions: This case emphasizes the proteiform aspects of Acanthamoeba drug resistance, and suggests that PHMB-chlorhexidine association might represent an additional option for cases resistant to standard therapy.
topic Acanthamoeba keratitis
Biguanide
Diamidine
url http://www.karger.com/Article/FullText/334270
work_keys_str_mv AT giulioferrari doublebiguanidetherapyforresistantacanthamoebakeratitis
AT stanislavmatuska doublebiguanidetherapyforresistantacanthamoebakeratitis
AT paolorama doublebiguanidetherapyforresistantacanthamoebakeratitis
_version_ 1724824859617263616